ONJ UPDATE 2018 CONGRESS ABSTRACTS Osteonecrosi delle ossa mascellari (ONJ) da bifosfonati e altri farmaci: prevenzione, diagnosi, farmacovigilanza, trattamento. Alessandria, 5 maggio 2018

MARIO MIGLIARIO; L. Tommasi; L. Benzi; C. Mortellaro; V. Fusco

doi:10.23736/S0026-4970.18.04215-2

ONJ UPDATE 2018 CONGRESS ABSTRACTS Osteonecrosi delle ossa mascellari (ONJ) da bifosfonati e altri farmaci: prevenzione, diagnosi, farmacovigilanza, trattamento. Alessandria, 5 maggio 2018

MARIO MIGLIARIO, L. Tommasi, L. Benzi, C. Mortellaro, V. Fusco

Dipartimento di Medicina Traslazionale

Risultato della ricerca: Contributo su rivista › Articolo in rivista › peer review

Abstract

This case apparently confirms that sunitinib-related and denosumab-related ONJ might have less pronounced CT alterations in comparison with those usually observed in BRONJ cases. However a possible aid to diagnosis from nuclear medicine techniques is deducible in this case, as well as recently described in BRONJ literature, reporting that bone scan might be more sensible (even if not specific) in identifying ONJ areas.

Lingua originale	Inglese
pagine (da-a)	17-18
Numero di pagine	2
Rivista	Minerva Stomatologica
Volume	67
Numero di pubblicazione	3
DOI	https://doi.org/10.23736/S0026-4970.18.04215-2
Stato di pubblicazione	Pubblicato - 1 gen 2018

Keywords

Bisphosphonate-Associated Osteonecrosis of the Jaw
Humans
Jaw Diseases
Osteonecrosis
Pharmacovigilance

Accesso al documento

10.23736/S0026-4970.18.04215-2

Altri file e collegamenti

handle

Cita questo

@article{84542fb5d80d4f7f8c50099dc4593766,

title = "ONJ UPDATE 2018 CONGRESS ABSTRACTS Osteonecrosi delle ossa mascellari (ONJ) da bifosfonati e altri farmaci: prevenzione, diagnosi, farmacovigilanza, trattamento. Alessandria, 5 maggio 2018",

abstract = "This case apparently confirms that sunitinib-related and denosumab-related ONJ might have less pronounced CT alterations in comparison with those usually observed in BRONJ cases. However a possible aid to diagnosis from nuclear medicine techniques is deducible in this case, as well as recently described in BRONJ literature, reporting that bone scan might be more sensible (even if not specific) in identifying ONJ areas.",

keywords = "Bisphosphonate-Associated Osteonecrosis of the Jaw, Humans, Jaw Diseases, Osteonecrosis, Pharmacovigilance, Bisphosphonate-Associated Osteonecrosis of the Jaw, Humans, Jaw Diseases, Osteonecrosis, Pharmacovigilance",

author = "MARIO MIGLIARIO and L. Tommasi and L. Benzi and C. Mortellaro and V. Fusco",

year = "2018",

month = jan,

day = "1",

doi = "10.23736/S0026-4970.18.04215-2",

language = "English",

volume = "67",

pages = "17--18",

journal = "Minerva Stomatologica",

issn = "1827-174X",

publisher = "Edizioni Minerva Medica S.p.A.",

number = "3",

}

ONJ UPDATE 2018 CONGRESS ABSTRACTS Osteonecrosi delle ossa mascellari (ONJ) da bifosfonati e altri farmaci: prevenzione, diagnosi, farmacovigilanza, trattamento. Alessandria, 5 maggio 2018. / MIGLIARIO, MARIO; Tommasi, L.; Benzi, L. et al.
In: Minerva Stomatologica, Vol. 67, N. 3, 01.01.2018, pag. 17-18.

Risultato della ricerca: Contributo su rivista › Articolo in rivista › peer review

TY - JOUR

T1 - ONJ UPDATE 2018 CONGRESS ABSTRACTS Osteonecrosi delle ossa mascellari (ONJ) da bifosfonati e altri farmaci: prevenzione, diagnosi, farmacovigilanza, trattamento. Alessandria, 5 maggio 2018

AU - MIGLIARIO, MARIO

AU - Tommasi, L.

AU - Benzi, L.

AU - Mortellaro, C.

AU - Fusco, V.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - This case apparently confirms that sunitinib-related and denosumab-related ONJ might have less pronounced CT alterations in comparison with those usually observed in BRONJ cases. However a possible aid to diagnosis from nuclear medicine techniques is deducible in this case, as well as recently described in BRONJ literature, reporting that bone scan might be more sensible (even if not specific) in identifying ONJ areas.

AB - This case apparently confirms that sunitinib-related and denosumab-related ONJ might have less pronounced CT alterations in comparison with those usually observed in BRONJ cases. However a possible aid to diagnosis from nuclear medicine techniques is deducible in this case, as well as recently described in BRONJ literature, reporting that bone scan might be more sensible (even if not specific) in identifying ONJ areas.

KW - Bisphosphonate-Associated Osteonecrosis of the Jaw

KW - Humans

KW - Jaw Diseases

KW - Osteonecrosis

KW - Pharmacovigilance

KW - Bisphosphonate-Associated Osteonecrosis of the Jaw

KW - Humans

KW - Jaw Diseases

KW - Osteonecrosis

KW - Pharmacovigilance

UR - https://iris.uniupo.it/handle/11579/112152

U2 - 10.23736/S0026-4970.18.04215-2

DO - 10.23736/S0026-4970.18.04215-2

M3 - Article

SN - 1827-174X

VL - 67

SP - 17

EP - 18

JO - Minerva Stomatologica

JF - Minerva Stomatologica

IS - 3

ER -

ONJ UPDATE 2018 CONGRESS ABSTRACTS Osteonecrosi delle ossa mascellari (ONJ) da bifosfonati e altri farmaci: prevenzione, diagnosi, farmacovigilanza, trattamento. Alessandria, 5 maggio 2018

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo